Secondary Logo

Journal Logo

Articles by Sikhulile Moyo

High Incidence of tuberculosis in the first year of antiretroviral therapy in the Botswana National ART programme between 2011 and 2015

Mupfumi, Lucy; Moyo, Sikhulile; Shin, Sanghyuk S.; More

AIDS. ., Post Acceptance: September 03, 2019

Low rates of nucleoside reverse transcriptase inhibitor and nonnucleoside reverse transcriptase inhibitor drug resistance in Botswana

Moyo, Sikhulile; Gaseitsiwe, Simani; Zahralban-Steele, Melissa; More

AIDS. 33(6):1073-1082, May 1, 2019.

Four-class drug-resistant HIV-1 subtype C in a treatment experienced individual on dolutegravir-based antiretroviral therapy in Botswana

Seatla, Kaelo K.; Avalos, Ava; Moyo, Sikhulile; More

AIDS. 32(13):1899-1902, August 24, 2018.

Undisclosed antiretroviral drug use in Botswana: implication for national estimates

Moyo, Sikhulile; Gaseitsiwe, Simani; Powis, Kathleen M.; More

AIDS. 32(11):1543-1546, July 17, 2018.

HIV transmission and 24-month survival in a randomized trial of HAART to prevent MTCT during pregnancy and breastfeeding in Botswana

Shapiro, Roger L.; Kitch, Douglas; Ogwu, Anthony; More

AIDS. 27(12):1911-1920, July 31st, 2013.

Non-nucleoside reverse transcriptase inhibitor outcomes among combination antiretroviral therapy-treated adults in Botswana

Wester, C William; Thomas, Ann Muir; Bussmann, Hermann; More

AIDS. 24:S27-S36, January 2010.